Point72 Hong Kong LTD Cytokinetics Inc Transaction History

Point72 Hong Kong LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $340,743 - $577,580	5,345 New	5,345 $374,000
Q4 2021 Feb 14, 2022	SELL	$34.35 - $46.38 $480,556 - $648,856	-13,990 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $85,005 - $163,867	4,585 Added 48.75%	13,990 $500,000
Q2 2021 Aug 16, 2021	BUY	$19.79 - $26.99 $172,984 - $235,919	8,741 Added 1316.42%	9,405 $186,000
Q1 2021 May 17, 2021	BUY	$18.57 - $25.68 $4,196 - $5,803	226 Added 51.6%	664 $15,000
Q4 2020 Feb 16, 2021	BUY	$15.26 - $28.61 $6,683 - $12,531	438 New	438 $9,000
Q4 2019 Feb 14, 2020	SELL	$7.95 - $11.84 $1,216 - $1,811	-153 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$10.82 - $14.25 $1,655 - $2,180	153 New	153 $2,000
Q2 2018 Aug 14, 2018	SELL	$6.9 - $9.9 $2,421 - $3,474	-351 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$7.2 - $10.05 $2,527 - $3,527	351 New	351 $3,000

407

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.31B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.